Serum apolipoproteins in the patients of myocardial infarction in different age groups

R Sharma1, V S Singh

  • 1Department of Biochemistry, L.L.R.M. Medical College Meerut, Meerut, India.

Insights

Serum Apo A-1 and Apo-B levels are better indicators of coronary artery disease risk than traditional lipid profiles in myocardial infarction survivors. These apolipoproteins show significant changes post-infarction.

Area of Science:

  • Cardiology
  • Biochemistry
  • Lipid Metabolism

Background:

  • Myocardial infarction (MI) survivors often exhibit altered lipid profiles.
  • Traditional lipid parameters like cholesterol and HDLc may not fully capture cardiovascular risk post-MI.

Purpose of the Study:

  • To evaluate serum lipid and apolipoprotein levels in MI survivors.
  • To determine if apolipoproteins are superior markers for coronary artery disease (CAD) compared to standard lipids.

Main Methods:

  • Analysis of serum cholesterol (Ch), HDLc, LDLc, VLDLc, Triglyceride (Tg), Apolipoprotein A-1 (Apo A-1), and Apolipoprotein B (Apo B) in 151 MI survivors.
  • Comparison of these markers across different age groups.

Main Results:

  • Significant increases observed in triglyceride, LDLc, and Apo B levels.
  • Significant decreases noted in Apo A-1 levels and the Apo A-1/B ratio.
  • No significant alterations in total cholesterol or VLDLc, with exceptions in specific age groups for HDLc.

Conclusions:

  • Serum Apo A-1 and Apo B demonstrate significant alterations in MI survivors.
  • Apolipoproteins may serve as more sensitive biomarkers for CAD than traditional lipid parameters.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...